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ABSTRACT
In the context of drug discovery and development, much effort has been exerted to
determine which conformers of a given molecule are responsible for the observed biological
activity. In this work we aimed to predict bioactive conformers using a variant of supervised
learning, named multiple-instance learning. A single molecule, treated as a bag of conformers, is
biologically active if and only if at least one of its conformers, treated as an instance, is
responsible for the observed bioactivity; and a molecule is inactive if none of its conformers is
responsible for the observed bioactivity. The implementation requires instance-based embedding,
and joint feature selection and classification. The goal of the present project is to implement
multiple-instance learning in drug activity prediction, and subsequently to identify the bioactive
conformers for each molecule.
We encoded the 3-dimensional structures using pharmacophore fingerprints which are
binary strings, and accomplished instance-based embedding using calculated dissimilarity
distances. Four dissimilarity measures were employed and their performances were compared. 1norm SVM was used for joint feature selection and classification. The approach was applied to
four data sets, and the best proposed model for each data set was determined by using the
dissimilarity measure yielding the smallest number of selected features.
The predictive abilities of the proposed approach were compared with three classical
predictive models without instance-based embedding. The proposed approach produced the best
predictive models for one data set and second best predictive models for the rest of the data sets,
ii

based on the external validations. To validate the ability of the proposed approach to find
bioactive conformers, 12 small molecules with co-crystallized structures were seeded in one data
set. 10 out of 12 co-crystallized structures were indeed identified as significant conformers using
the proposed approach.
The proposed approach was demonstrated to be highly competitive with classical
predictive models, hence it is very powerful for drug activity prediction. The approach was also
validated as a useful method for pursuit of bioactive conformers.
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BACKGROUND
In the context of drug discovery research, it is challenging but of great importance to be
able to determine which 3-dimensional (3D) shapes (so-called conformers) of a given molecule
are responsible for its observed biological activity. Due to structural flexibility, a molecule may
adopt a wide range of conformers and the identification of the bioactive conformers is extremely
important in order to understand the recognition mechanism between small molecules and
proteins, which is crucial in drug discovery and development. Until now, the most reliable
approach to obtain the bioactive conformer is to use the X-ray crystal structure of a ligandprotein complex; however, the number of such structures is limited because of the experimental
difficulty in obtaining the crystals, especially for transmembrane proteins, such as G proteincoupled receptors (GPCR) [1, 2] and membrane transporters. We were interested to apply to this
problem a machine-learning approach which does not require crystal structures, named multipleinstance learning (MIL) via embedded instance selection (MILES). MILES has been
demonstrated as an efficient and accurate approach to solve different multiple-instance problems
[3], in particular, to predict drug activity using Musk data sets. In the context of drug activity
prediction, MILES enables the construction of a quantitative structure-activity relationship
(QSAR) model, and subsequently the identification of bioactive conformers.
MIL is a variant of supervised learning, and it has been applied for a variety of learning
problems including drug activity prediction [4], image database retrieval [5], text categorization
1

[6], and natural scene classification [7]. In the context of drug activity prediction, the observed
biological activity is associated with a single molecule (bag) without knowing which conformer
or conformers (instances) are responsible. Furthermore, a molecule is biologically active if and
only if at least one of its conformers is responsible for the observed bioactivity; and the molecule
is inactive if none of its conformers is responsible (Figure 1). A difficulty in implementation
arises from the fact that different molecules have a different number of conformers, since some
molecules having multiple rotatable bonds are highly flexible and others with rigid structures
only have a small numbers of conformers (Figure 2).

Figure 1. Cartoon representation of the relationsip between molecules and conformers.
Mi, i=1, 2, 3, 4 represent the molecules (bags), circled by dashed lines. The solid triangles in M1,
circles in M2, squares in M3, and stars in M4 represent conformers for different molecules.
Molecules 2, 3, and 4 were biologically active since they had at least one bioactive conformer,
whereas molecule 1 was inactive since none of its conformers was bioactive. The distance
between two molecules, M1 and M3, was calculated by the minimum distance D(M1, M3).
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Figure 2. Three molecules with various numbers of conformers.
Since losartan has multiple rotatable bonds represented by various dihedral angles, Φk, k =
1,2,3,4,5, it adopts a large number of conformers and only one of them is responsible for the
bioactivity, which is called bioactive conformer. However, the other two molecules, paullone and
indirubin, can only adopt single conformer which is the bioactive one.
The overall strategy for structural and data mining using MILES (Figure 3) is
summarized here. First of all, a complete sampling of conformational space provides a large
number of conformers for each molecule. The molecules are themselves each already labelled as
either positive or negative. However, the labels for the conformers are unavailable during the
model generation. Each conformer is denoted by a unique pharmacophore fingerprint which is a
superior feature-based 3D descriptor unveiling structural similarity and diversity [8-11]. The
pharmacophore fingerprint is encoded into a binary string which indicates the presence or
absence of a match to individual pharmacophore models. Since the exhaustively enumerated
fingerprints have millions of bits, which may be beyond computational limits, a significance
analysis of pharmacophore models [12] is employed to determine the optimal subset of bits of
3

the fingerprint. Subsequently, MILES converts the MIL to a standard supervised learning
problem by embedding bags (molecules) into an instance-based (conformer-based) feature space
via structural dissimilarity measures [13]. Finally, 1-norm SVM is applied to select the most
important features, identifying the highly significant conformers which help the most to
distinguish active and inactive molecules, and, simultaneously, to construct a predictive
classification model.

Figure 3. Overview of the MILES approach.
(1) Structure preprocessing and conformational sampling. (2) Creating pharmacophore
fingerprints and significance analysis of pharmacophore models. (3) Instance-based feature
mapping based on structural similarity measures. (4) Joint feature selection and classification
using 1-norm SVM.
In the present work, MILES has been applied to study the biological activities of several
sets of molecules interacting with different receptor targets including glycogen synthase kinase-3
(GSK-3), cannabinoid receptors (CBrs), and P-glycoprotein (P-gp). All of these receptors have
4

been emerging as increasingly important therapeutic targets. GSK-3 is a multifunctional
serine/threonine protein kinase involved in the regulation of a wide range of cellular functions,
including glucose metabolism, neuronal processes, chronic inflammation, cell proliferation and
apoptosis [14]. CBrs are a class of GPCRs and have been targeted for various disease conditions
such as obesity, drug abuse disorders, inflammatory diseases, anorexia and vomiting [15]. P-gp,
a membrane transporter, is responsible for drug efflux and multidrug resistance, especially to
cancer drugs [16]. Except for GSK-3, the other proteins are membrane-associated and there is no
available crystal structure for them. The identification of bioactive conformers for the molecules
targeting membrane-associated proteins using MILES could be highly informative and desirable.
Identified conformers can be used in various drug discovery approaches such as scaffold
hopping, target fishing, and 3D structural alignment for 3D quantitative structure-activity
relationship (QSAR) studies.
Based on our calculations, MILES is highly competitive with the classical QSAR
approaches which do not include instance-based feature mapping in terms of predictive abilities.
Meanwhile, we have validated that MILES has the ability to identify a subset of highly relevant
conformers, including the bioactive conformers, which contribute to the classification of active
and inactive molecules.

5

METHODOLOGY
Data Set Preparation
Four different data sets were compiled through extensive literature search. Data set I
includes all molecules exhibiting inhibitory activities for human GSK-3. Data sets II and III
contain molecules modulating the intracellular activities of human CBrs. Since there are two
identified CBr subtypes, CB1 and CB2, two different data sets were prepared to study the
protein-small molecule interactions of the receptors separately. Some of the molecules which
have reported binding affinities for both CB subtypes were included in both data sets II and III.
Data set IV contained compounds which had been tested as substrates of P-gp.
The molecules collected for each data set were labelled as either positive or negative. A
positive molecule has a high binding affinity with the target protein, whereas a negative
molecule has a low binding affinity. A single cutoff value has been widely used in the
development of classification models. However, it is inaccurate to use a single cutoff value for
the separation of continuous biological activities in the context of drug activity prediction. The
biological activities are represented by continuous numbers, and the small differences between
the values above and below the cutoff value cannot imply the distinct nature of binding affinity.
Furthermore, the small difference in the bioassay results may arise from systematic errors
introduced by different experimental protocols used in different labs, so it cannot be used as solid
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evidence for the classification of molecules. Therefore, multiple cutoff values were employed to
separate molecules into positive and negative classes.
For data set I, the molecules were categorized into positive and negative molecules using
cutoff values of IC50 ≤ 50 nM and IC50 ≥ 500 nM, respectively. The molecules having inhibitory
activities between the two cutoff values were considered as moderately active molecules, and
were discarded from the data set. The wide margin between the two cutoff values was used to
account for the variances in biological assays. For data set II and III, the molecules were
classified as positive if the Ki ≤ 50 nM or IC50 ≤ 100 nM or EC50 ≤ 100 nM (IC50 is
approximately twice as large as Ki based on the definition); and the molecules were classified as
negative if the Ki ≥ 500 nM or IC50 ≥ 1000 nM or EC50 ≥ 1000 nM. The labels for the molecules
in data set IV indicated whether or not the molecule is a substrate for the target protein. They
were obtained from the literature [12].
Division of Training and Test Set
External validation was achieved using an independent test set. The split of the data set
into training and test sets was carried out using Kohonen self-organizing maps (SOM) in Canvas
1.4 from Schrödinger Suite 2011. The SOM is trained using unsupervised learning to produce a
square 2D grid map from the high dimensional input space. Each grid cell (neuron) contains a
cluster of structurally similar molecules defined by the input vectors. The SOM takes advantage
of clustering capabilities so that the selected training set can represent the independent test set in
terms of the input space and chemical domains. Molecular pharmacophore fingerprints were
used to describe the relevant structural information of the molecules and were used as input
variables to build the SOM. The grid size of the map depends on the number of molecules in the
7

data set. For data sets I, II, and III, the Kohonen maps built included 10 10 neurons and 500
epochs. For the data set IV, a Kohonen map consisting of 8 8 neurons and 500 epochs was built.
The molecules were then stratified and sampled from each neuron to select the training and test
set molecules.
Preprocessing and Conformational Sampling
The molecules (bags) can be represented by Mi, i=1,···,l where l is the total number of
molecules. The 3D molecular structures were generated using the Ligprep module from
Schrödinger Suite 2011, and then subjected to preprocessing to enumerate all the possible
tautomers. The protonation states of ionizable groups were set to match pH = 7.4, and the
stereochemistry was retained from the original 3D structures. In order to explore the
conformational space exhaustively, the mixed torsional/low mode sampling method was
employed, using MacroModel from Schrödinger Suite 2011. The torsional sampling involves
multiple Monte Carlo minimum searches for global exploration, and the low mode
conformational search allows for automatic local exploration. The torsional increment for each
rotatable bond was set to 15° and the maximum number of total steps for torsional sampling was
1,000. The energy window for saving structures was set to 83.7 kJ/mol (20 kcal/mol). The small
torsional increment and wide energy window were employed to provide a reasonable coverage of
the conformational space. Each enumerated conformer was energy minimized to eliminate
unreasonable geometries and reduce internal steric clashes, using the Polak-Ribière conjugate
gradient method with a gradient convergence threshold of 0.05 and a maximum of 500 iterations.
To remove redundant conformations, the maximum atom deviation cutoff was set to 1.5 Å. As a
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result, each molecule Mi has several possible conformers Cij, j=1,···,ni, where ni is the number of
conformers (instances) for molecule i.
In order to validate that MILES can identify the bioactive conformers, we seeded 12 cocrystallized conformers, one for each of 12 molecules, in the set of sampled conformers for data
set I. The validation process will be described in the following sections.
Generation of Pharmacophore Fingerprints
The pharmacophore fingerprint as a measure of molecular similarity and diversity based
on 3D pharmacophoric shape was enumerated using Canvas 1.4 from Schrödinger Suite 2011.
Each pharmacophore fingerprint associated with a unique conformer can be represented by a
binary string, such as Pij = {p1,···,pk, ···,pm} and encodes quantitative structural information for
conformer Cij, where each bit value pk, k=1,···,m indicates the presence or absence of a match to
a single pharmacophore model, representing a unique 3D arrangement of a number of
pharmacophore features. If the conformer fits the pharmacophore model for a particular k, in
other words if the functional groups of the conformer fully overlap on all the pharmacophore
features in the model, pk equals 1; otherwise, pk equals 0. As a result, each conformer is
associated with a unique pharmacophore fingerprint as a conformational signature, which
enables us to describe quantitatively the 3D structural information (Figure 4). The
pharmacophore features employed in the models consist of hydrogen bond donor (D), hydrogen
bond acceptor (A), hydrophobic group (H), negatively charged group (N), positively charged
group (P), and aromatic ring (A). In the present study, only four-feature based models were
employed in order to allow a reasonable description of 3D orientation of the structures and retain
information about molecular chirality, which is lost in three-feature based models. Different
9

combinations of four out of six pharmacophore features were exhaustively enumerated and interfeature distances were varied from 2.0 Å to 20.0 Å to form the different pharmacophore models.
Each pharmacophore feature was treated as a bin with width 2.0 Å, and the bin overlap threshold
was 1.0 Å. To fit to a model the conformer must fit to each of the four features in the model. The
maximum distance between pharmacophore features was set to 20.0 Å in order to be able to
cover the largest molecular structures in the databases. To obtain a unique pharmacophore
fingerprint for single molecule, binary union operation was applied on a bag of pharmacophore
fingerprints for the conformers adopted by that molecule (Figure 5). The originally enumerated
fingerprints were subject to occurrence-based filtering to remove the pharmacophore models
present in less than 5% of the total number of molecules, since the pharmacophore models with a
very low occurrence are not useful for discriminating between positive and negative classes.

Figure 4. Pharmacophore fingerprint for single conformer.
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Figure 5. Pharmacophore fingerprint for single molecule.
Significance Analysis of Pharmacophore Models
The post-filtered pharmacophore fingerprints still have too many bits that lack
information content, as indicated by too many „0‟ values. Therefore a nonparametric supervised
learning approach, motivated by the significance analysis of microarrays (SAM) algorithm
proposed by Tibshirani et al. [17], was applied to elucidate a consistent pattern from the
numerous bits of pharmacophore fingerprints. The detailed implementation and customization of
the relevant procedures has been described in [12]. The ranking score for each pharmacophore
model was computed based on a two-class t-statistic, which calculates the ratio of the difference
of occurrences of that model in positive and negative classes and compares to the standard
deviation of occurrence measures. Pharmacophore models with ranking scores greater than a
threshold have statistical significance, where the threshold was computed at the 90th percentile
among 500 random permutations of the class labels across all the molecules. In order to
distinguish truly significant and falsely significant pharmacophore models, that ranking score
serving as a true score was then compared with a reference score computed from the same set of
random permutations. If the difference between the true score and the reference score exceeds a
11

cutoff threshold (called Δ) then the pharmacophore model is truly significant; otherwise it is
falsely significant. .
Instance-based Feature Mapping
MILES provides a framework to convert a MIL problem to a standard supervised
learning problem via instance-based embedding. All the conformers (instances) belong to the
instance-based feature space. For convenience, all conformers in all molecules were lined up
together, and were re-indexed in the embedded feature space as Cr, r=1,···,n where

.

Instance-based feature mapping can be accomplished using calculated structural dissimilarities.
Different binary string distance measures were tested, including the Soergel distance, Dice
distance, Manhattan distance, and Rogers-Tanimoto distance (Table 1). The range of each
dissimilarity measure was normalized to be [0, 1] by definition. Given a conformer Cij denoted
by a binary string Pij, the dissimilarity measure, denoted as D(Cij, Cr), is calculated based on the
number of occurrences of bit matches. Since one molecule is defined as a bag of multiple
conformers (instances), the dissimilarity measure for a molecule, denoted as D(Mi, Cr), is
calculated based on the minimum distance using the closest instance in the bag for Mi:

(1)

The minimum distance calculation (Figure 1) extends the idea of the diverse density framework
proposed for instance-based learning [18].
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Table 1. Metrics used for dissimilarity measurements.
Definitiona

Dissimilarity Measure
Soergel
Dice
Manhattan
Rogers-Tanimoto
a

Let P1 and P2 be two pharmacophore fingerprints, a be the count of bits which are set to 1 in
both P1 and P2, b be the count of bits which are set to 1 in P1 but not in P2, c be the count of bits
which are set to 1 in P2 but not in P1, and d be the count of bits which are set to 0 in both P1 and
P2. So a is called the number of total matches, b and c are called the number of single matches,
and d is called the number of no matches.
Joint Feature Selection and Classification
Since the molecules in the training sets are highly flexible, instance-based embedding,
which provides a framework to convert a MIL problem to a traditional supervised learning
problem, may produce a very high dimensional feature space. But many features are redundant
or irrelevant, and do not play an important role in the classification of molecules as positive or
negative. So an efficient feature selection model is required for selection of an optimal subset of
instance-based features. Considering its excellent performance in many applications [19], the 1norm SVM method was chosen as a joint approach to construct classifiers and to select important
features simultaneously. The prediction model can be formulated as a linear classifier,
(2)
where

denotes the class label as either positive or negative;

and

are model parameters

which are optimized during model generation; and m corresponds to a molecule (bag), which is
defined by an n-dimensional vector of dissimilarities calculated using (1), i.e., dissimilarities
13

with respect to all conformers in all molecules. The domain to (2) is therefore the space of Rn,
where n is the sum of all conformers in all molecules. The SVM approach constructs classifiers
based on hyperplanes by minimizing a regularized training error, ξtraining (hinge loss),
λP[•] + ξtraining

(3)

where P[•] is a regularizer, and λ is the regularization parameter, the only tuning parameter to be
optimized by the user. In 1-norm SVM, the regularizer is chosen to be the 1-norm of the weight
vector,
(4)

.

1-norm regularization favors sparse solutions, i.e., it drives many components of
Once the optimal solution, with values
component

and

to zero.

, is obtained, the magnitude of its

indicates the significance of the r-th feature (conformer) in the instance-based

feature space. The features corresponding to non-zero entries in
features, whose indices are specified as a set

are selected as important
). They are needed for the

classification problem of interest
.

(5)

Note that (2) is equivalent to (5) where all weights with 0 values are ignored. The domain of (5)
is R|Γ|, a subspace of Rn, defined by conformers whose weights are nonzero. The features
selected as important are called prototype conformers. The plus or minus sign of

indicates the

positive or negative contribution, respectively, of the r-th prototype conformer to the putative
bioactive conformers for each individual molecule.
14

Our formulation of MILES works directly on a dissimilarity mapping, which is different from a
similarity mapping described by Chen, et al. [3]. One can transform a dissimilarity mapping to a
similarity mapping via an exponential function. However, this would introduce an additional
super parameter, σ. Although, a proper choice of σ could improve the performance of a model,
the selection of a proper value for σ increases the computational cost significantly. Hence we use
a dissimilarity mapping to reduce the computational cost.
Identification of Bioactive Conformers
One appealing advantage of the MILES algorithm is that it can identify the most
significant instances in a bag according to their contributions to the classification of that bag. In
the context of drug activity prediction, we can identify the most significant conformers, called
the bioactive conformers, for each molecule. The putative bioactive conformers are the
conformers that contributed the most to the classification of positive and negative molecules.

Figure 6. Identification of bioactive conformers.
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Molecule i was circled by a dashed line and its conformers were represented by solid triangles.
The plus circles represent the positively contributing prototype conformers and the minus circles
represent the negatively contributing prototype conformers. The identification of bioactive
conformers was accomplished by calculating the total contributions from the closest prototype
conformers.
The identification of bioactive conformers can be accomplished with the assistance of the
prototype conformers mentioned above (Figure 6). Given a molecule Mi with its conformers Cij,
j=1,···,ni, we define an index set

), which includes the

index for conformers closest to each prototype conformer. Hence,

defines a minimal set of

conformers, called significant conformers, which are responsible for the classification of Mi. By
definition, each prototype conformer in set
each significant conformer in set

has a single conformer in set

may have multiple prototype conformers in set

So we need to define an index set for each significant conformer in set
for

the

prototype

closest to it, but

conformers

closest

to

it,

closest to it.

that includes the index

which

is

given

as

). As a result, the contribution of each significant
conformer to the classification of molecule can be calculated as

(6)

where

denotes the contribution of the conformer

Mi. The conformer in set

to the classification of the molecule

making the highest contribution is selected as a bioactive conformer.

In order to validate the ability of MILES to identify the bioactive conformers, the
contributions

for the 12 seeded conformers, which were taken directly from co-
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crystallized complex structures, were calculated and ranked among all the conformers sampled
for those 12 molecules.
Classical QSAR Methods without Instance-based Embedding
In order to examine the predictive performance of MILES, conventional classification
approaches based on classical QSAR principles without instance-based embedding were tested
for comparison. Since one molecule is defined as a bag of multiple conformers (instances), the
pharmacophore fingerprint associated with a single molecule was obtained from the binary union
of all of the pharmacophore fingerprints associated with the conformers of that molecule. The
same occurrence-based filtering and significance analysis of pharmacophore fingerprints were
performed to select the optimal subsets of the fingerprints which constituted the feature space for
the classical QSAR studies. Three widely used classification algorithms including decision tree
(DT) [20], 1-norm SVM [19], and random forest [21] were employed for comparison with
MILES-SVM. The decision tree is a greedy method based on a recursive partitioning algorithm.
The classification trees were constructed using the „classregtree‟ function implemented in Matlab
R2011b. The tree-based classification method can account well for multiple binding mechanisms
[12]. Gini‟s diversity index was used for recursive partitioning, and the minimal number of
molecules per tree leaf was set as 3 to terminate tree growing. The 1-norm SVM model is a
statistical learning theory derived from the structural risk minimization principle and VapnikChervonenkis (VC) dimension [22]. It is different from the tree-based method and served as an
alternative comparison. Since the major drawback of DT is its low prediction caused by the
overfitted tree-based structure, the ensemble learning method, random forests [21], can deliver
improved prediction while retaining the appealing properties of tree-based methods. It is a
17

collection of decision trees which are grown from bootstrapping samples of the original data
without tree pruning, and has been demonstrated as one of the most powerful tools available for
data exploration [23]. The Matlab implementation (randomforest-matlab v0.02) was used with
default parameters.
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RESULTS AND DISCUSSION
Data Set Preparation and Division
According to the criteria used to label positive and negative molecules, the number of
molecules in each of two classes was balanced for four data sets. Data set I has 266 molecules as
positive and 258 molecules as negative; data set II has 253 molecules as positive and 284
molecules as negative; data set III has 307 molecules as positive and 188 molecules as negative;
and data set IV has 122 molecules as positive and 128 molecules as negative. In terms of
division of training and test sets, a stratified sampling was used to partition all four data sets into
training and test sets at ratios around 3:1, respectively (Table 2).
Table 2. Data set statistics.
Data No. of molecules in training set

No. of molecules in test set

set

Positive

Negative

Positive

Negative

Total no. of
molecules

I
II
III
IV

199
191
247
94

188
210
131
93

67
62
60
28

70
74
57
35

524
537
495
250

Conformational Sampling
The molecules in different data sets had various conformational flexibilities, so the
average number of conformers for each molecule was distinct for the four data sets (Table 3).
The average number of conformers for each molecule was 43 in data set I, 89 in data set II, 86 in
data set III, and 211 in data set IV. So the molecules in data set IV had the highest
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conformational flexibility. The feature space constructed through instance-based embedding only
consisted of the instances from training bags, in other words, the conformers from the molecules
in the training set. The molecules in the test set were not used in the construction of the instancebased feature space. So ntraining in Table 3 indicates the number of instance-based features used
for embedding.
Table 3. Conformational sampling and pharmacophore fingerprints.
Data
ntraininga
ntestb
mpre-filteringc mpost-filteringd msignificante
Δ*f
set
17249
5399
1872521
243721
2979
1.77
I
35434
12333
1670985
155220
14002
5.40
II
32528
9942
1636254
145996
1542
1.80
III
41960
10746
13687602
161018
3467
1.66
IV
a
The number of conformers in the training set; b the number of conformers in the test set; c the
number of pharmacophore bits in the fingerprint originally enumerated; d the number of
pharmacophore bits in the fingerprint after filtering; e the number of bits in the optimal subset of
the pharmacophore fingerprint; f the optimal threshold value to select truly significant
pharmacophore bits.
Significance Analysis of Pharmacophore models
Millions of pharmacophore models were originally enumerated for each data set, and the
largest number of pharmacophore models was generated for data set IV. This correlated with the
observation that the molecules in data set IV have the highest conformational flexibility. After
occurrence-based filtering, only a small portion of the pharmacophore models was retained for
each data set. For instance, 13% was retained for data set I, 9% for both data sets II and III, and
1% for data set IV (Table 3).
Significance analysis was subsequently performed upon those retained pharmacophore
models. The threshold values were set to 100 equally spaced intervals from 0 to the largest
difference between the ranking scores and reference scores. As the threshold value increases in a
20

bottom-up manner, the number of falsely significant pharmacophore models decreases, and the
number of truly significant models remains roughly constant. So the optimal threshold values
(Δ*) for each data set can be obtained when the number of falsely significant pharmacophore
models drops to zero (Table 3). Subsequently, the optimal subsets of the pharmacophore
fingerprint bits were obtained for four data sets (Table 3). Only a very small portion of the
fingerprint bits were significant for classification, namely 1% in data set I, 9% in data set II, 1%
in data set III, and 2% in data set IV.
In the context of MIL, the optimal subsets of the binary strings were used to calculate the
dissimilarity between two conformers for instance-based feature mapping. For the classical
QSAR methods, the optimal subsets of the fingerprints were used as the 3D descriptors in the
pharmacophore-based feature space for building classification models.
Predictive Performance of MILES and Classical QSAR methods
In the MILES model, the only tuning parameter λ was determined by a grid search. Five
replications of 5-fold cross-validation were performed to assess the classification accuracies at
each point over a fixed grid which ranged from 2-8 to 25 with exponential increment in base 2.
The median values for the 5 replications were used to find the optimal tuning parameters. During
the cross-validation, the instance-based feature space was dynamically defined, which means that
the conformers from the molecules in the internal test set, after random split of the training set,
were excluded from the feature space. As a result, the optimal tuning parameters as well as the
number of prototype conformers were obtained for four dissimilarity measures (Table 4).
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Table 4. Optimization of tuning parameter λ for MILES.
Data set
Dissimilarity measure
Cross-validationa
λ
nb
Soergel
0.777
8.000
196
Dice
0.761
4.400
165
I
c
Manhattan
0.803
4.400
130
Rogers-Tanimoto
0.801
4.000
153
Soergel
0.865
0.001
103
Dice
0.865
0.001
85
II
c
Manhattan
0.877
0.022
63
Rogers-Tanimoto
0.868
0.069
72
Soergel
0.899
0.001
94
Dice
0.901
0.001
75
III
Manhattan
0.934
0.550
63
c
Rogers-Tanimoto
0.935
4.400
46
Soergel
0.579
0.003
125
Dice
0.544
0.031
111
IV
Manhattan
0.690
0.550
87
c
Rogers-Tanimoto
0.689
6.800
78
a
b
The median classification accuracy for 5 replications of 5-fold cross-validation; the number of
prototype conformers selected in the set ; c The model selected based on the number of
prototype conformers.
Based on the internal validation, the classification accuracies were similar within each
data set using four different dissimilarity measures. However, the numbers of prototype
conformers selected were much different. For instance, in data set I and II, Manhattan distance
yielded the smallest subset of selected prototype conformers, but in data set III and IV, RogersTanimoto yielded the smallest subset. Furthermore, Soergel distance yielded the largest subset
for all the four data sets. The dissimilarity measure which yielded the smallest number of
selected prototype conformers was chosen as the best MILES model and used later for
comparison with classical QSAR models without instance-based embedding.
After finding the optimal λ, a MILES model was identified from the training set and
applied to the test set. In addition to comparing classification accuracy, denoted as the proportion
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of correct predictions, Matthews Correlation Coefficient (MCC) [24] was also employed as a
complementary indicator for the predictive performance. MCC is defined as:

(7)

where TP is true positive, TN is true negative, FP is false positive, and FN is false negative.
MCC not only takes into account true positives and true negatives as classification accuracy
does, but also false positives and false negatives. Thus it is considered as a balanced measure of
the performance of binary classification (Table 5).
Table 5. Predictive performance for different dissimilarity measures.
Training set
Test set
Data set Dissimilarity measure
Accuracy
MCC
Accuracy
MCC
Soergel
0.972
0.944
0.854
0.714
Dice
0.979
0.959
0.825
0.653
I
Manhattana
0.941
0.881
0.861
0.725
Rogers-Tanimoto
0.961
0.923
0.861
0.725
Soergel
0.965
0.933
0.860
0.725
Dice
0.965
0.933
0.868
0.745
II
a
Manhattan
0.978
0.956
0.904
0.807
Rogers-Tanimoto
0.973
0.946
0.897
0.793
Soergel
0.989
0.977
0.846
0.706
Dice
0.989
0.977
0.855
0.717
III
Manhattan
0.979
0.954
0.838
0.686
Rogers-Tanimotoa
0.947
0.885
0.846
0.711
Soergel
0.904
0.823
0.667
0.301
Dice
0.904
0.823
0.635
0.307
IV
Manhattan
0.957
0.918
0.714
0.433
a
Rogers-Tanimoto
0.898
0.811
0.794
0.584
a
The model selected based on the number of prototype conformers.
In accordance to classification accuracy and MCC, the performance of different
dissimilarity measures was dataset-specific. For data set I, both the Manhattan and RogersTanimoto distances were top-ranked and performed equally well on the test set, whereas on the
23

training set, the Soergel and Dice distances performed much better than the Rogers-Tanimoto
and Manhattan distances, and the Rogers-Tanimoto distance performed slightly better than the
Manhattan distance. In addition, the results did not change after removing the 12 seeded
conformers which were used for the validation of identifying bioactive conformers. For data set
II, the Manhattan distance was top-ranked on both training set and test set. For data set III, the
Dice distance was top-ranked on both training and test sets. For data set IV, the RogersTanimoto distance performed much better on the test set, but on the training set it was not the
top-ranked dissimilarity measure. It is interesting that for data sets I, II, and III the differences in
the predictive performances of the four dissimilarity measures were very small, whereas for data
set IV the differences were much larger. This may be caused by the high structural diversity in
data set IV. The small difference in dissimilarity measures had a big impact on the predictive
performance. The other interesting observation was that the classification accuracy and MCC
provided the same indications for the predictive performance, which means that the data sets in
the present work were highly balanced and good for benchmark studies.
After comparing the predictive performance of different dissimilarity measures in the
MILES model, the predictive performance of MILES models was compared with that of
conventional classification approaches, which are based on classical QSAR principles without
instance-based embedding. To find the optimal λ for 1-norm SVM on the basis of classical
QSAR principles, the same procedure was employed, which resulted in the minimal subset of the
most important pharmacophore models (Table 6).
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Table 6. Optimization of tuning parameter λ for 1-norm SVM.
Data set
Cross-validationa
λ
nb
0.693
0.001
223
I
0.880
2.000
80
II
0.912
0.016
77
III
0.598
0.125
89
IV
a
The median classification accuracy for 5 replications of 5-fold cross-validation; b the number of
important pharmacophore bits.
For data set I, the 1-norm SVM without instance-based embedding overfit the training
set, producing perfect prediction on the training set and poor prediction on the test set. However,
MILES performed fairly well on both the training and test sets without overfitting. MILES
performed much better than decision trees and slightly worse than random forests in terms of the
predictive power on the test set. For data set II, MILES was highly competitive with the other
classical QSAR methods, yielding the second best prediction on both training and test sets, while
1-norm SVM without embedding provided the best prediction on the training set but suffered
from overfitting and decision trees produced the best prediction on the test set. For data set III,
MILES performed slightly worse than random forests, but better than the other two methods,
based on the predictions on the test set. Although MILES using Dice distance was not selected,
since it yielded a large number of selected prototype conformers, it performed equally as good as
random forests on the test set. For data set IV, MILES significantly outperformed the other
approaches based on the predictions on the test set. For all the data sets, 1-norm SVM without
embedding overfit the training set, yielding the best predictions on the training sets and relatively
low predictions on the test sets. However, after instance-based embedding, MILES performed
fairly well on both training and test sets without overfitting, and its predictive power was highly
comparable with other conventional QSAR approaches (Table 7). It was interesting that the

25

classification accuracy and MCC provided the same indications again, even for the comparison
of different QSAR approaches.
Table 7. Predictive performance for different models.
Training set
Test set
Data
Methods
set
Accuracy
MCC
Accuracy
MILESa
0.941
0.881
0.861
Decision tree
0.915
0.830
0.781
I
1-norm SVM
1.000
1.000
0.832
Random forest
0.995
0.990
0.891
a
MILES
0.978
0.956
0.904
Decision tree
0.955
0.913
0.919
II
1-norm SVM
0.980
0.961
0.882
Random forest
0.945
0.896
0.868
MILESb
0.947
0.885
0.846
Decision tree
0.966
0.924
0.838
III
1-norm SVM
0.995
0.988
0.812
Random forest
0.982
0.959
0.855
b
MILES
0.898
0.811
0.794
Decision tree
0.914
0.829
0.698
IV
1-norm SVM
0.952
0.906
0.714
Random forest
0.936
0.877
0.698
a
b
Manhattan dissimilarity measure; Rogers-Tanimoto dissimilarity measure.

MCC
0.725
0.569
0.668
0.783
0.807
0.837
0.765
0.754
0.711
0.682
0.624
0.717
0.584
0.398
0.418
0.392

Identification of Bioactive Conformers
After examining the predictive ability of MILES, we tested the ability of MILES in the
pursuit of the bioactive conformers. Due to the lack of experimental data, the validation can only
be made for the molecules in data set I. We made use of 12 co-crystallized structures of GSK-3
with bound small molecules, which adopt bioactive conformers in the complex structures (Table
8). The direct comparison between the structures of the co-crystallized conformers and the ones
from conformational sampling is difficult and sometimes impossible, since the conformational
sampling plus structural minimization may not provide the exact same conformations found in
the co-crystallized complex, due to the lack of protein environment in the conformational search
process. So we adopted an indirect validation method. We seeded the 12 co-crystallized
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conformers in the set of sampled conformers generated through extensive exploration of
conformational space. Then we calculated their contributions

to the classification of the

relevant positive molecules as described above (Table 8).
Table 8. Validations on the prediction of bioactive conformers.
IDa
Nameb
PDB IDc
Contributiond
23
AR
1Q5K
2.792
37
Benzoimidazole-1
2O5K
0
50
Jonjon-1
2OW3
2.827
59
LM-4
1Q3W
0.858
60
LM-5
1UV5
11.941
77
LM-29
1Q41
8.576
97
Maleimide
1R0E
0
98
OxaD-0
3F7Z
10.629
99
OxaD-00
3GB2
4.637
153
Pyzo-11
3L1S
10.371
198
RM-0
1Q4L
5.568
199
Staurosporine
1Q3D
22.359

Ranke
3
N.A.g
6
1
1
2
N.A. g
1
2
1
2
1

nif
117
138
38
2
3
7
121
53
9
11
25
5

a

Molecule index in the data set; b molecular name in the data set; c Protein Data Bank index for
the protein structure from which the experimental conformer was extracted; d contribution
calculated using equation 6; e the rank in the set of contributions; f the number of
conformers for each molecule; g the rank cannot be determined and the conformer was predicted
to be irrelevant to classification based on the MILES method.
Three out of 12 molecules are highly flexible, adopting more than 100 conformers. For
these three, MILES only correctly predicted one co-crystallized conformer as the third most
significant conformer contributing to the classification of the molecule named AR. It incorrectly
predicted the other two co-crystallized conformers as irrelevant conformers in terms of the
contribution to the classification of benzoimidazole-1 and maleimide.
But for the molecules adopting less than 100 conformers, which had relatively rigid
structures, MILES correctly predicted all the co-crystallized conformers as significant
conformers for the classification of positive molecules. Five co-crystallized conformers were
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predicted to be the most significant conformers, i.e., the bioactive conformers; three cocrystallized conformers were predicted to be the second most significant conformers; and one cocrystallized conformer was predicted to be the sixth most significant conformer, based on the
calculations of

. So the pursuit of bioactive conformers is easy for relatively rigid

molecules and relatively more difficult for the highly flexible ones.
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CONCLUSIONS
We have successfully implemented a multiple-instance learning (MIL) framework,
multiple-instance learning via embedded instance selection (MILES), for drug activity
prediction. The molecules and relevant conformers were described using superior 3D descriptors,
pharmacophore fingerprints, encoded as binary strings. The instance-based embedding was
accomplished using dissimilarity measures designed for calculations on binary strings. The joint
feature selection and classification was accomplished using a wrapper model based on 1-norm
SVM. We have used the approach for the prediction of the labels of molecules interacting with
four therapeutic targets, including GSK-3, CBrs, and P-gp. Based on the predictive performance,
our proposed approach was highly competitive with conventional classification approaches based
on classical QSAR principle. However, the proposed method, unlike conventional classification
approaches, can also predict the contributions of individual conformers for each molecule and
further can identify the putative bioactive conformer. These unique characteristics make the
proposed method very useful for the pursuit of biologically significant conformers. Finally, we
have validated that the proposed approach is highly useful in the pursuit of bioactive conformers.

29

BIBLIOGRAPHY

30

1.

2.
3.
4.
5.
6.
7.
8.
9.

10.

11.

12.

13.
14.
15.
16.

17.
18.

Fanelli F, De Benedetti PG: Computational modeling approaches to structurefunction analysis of G protein-coupled receptors. Chemical Reviews 2005,
105(9):3297-3351.
Klabunde T, Hessler G: Drug design strategies for targeting G-protein-coupled
receptors. ChemBioChem 2002, 3(10):928-944.
Chen Y, Bi J, Wang JZ: MILES: Multiple-instance learning via embedded instance
selection. IEEE T Pattern Anal 2006, 28(12):1931-1947.
Dietterich TG, Lathrop RH, Lozano-Perez T: Solving the multiple instance problem
with axis-parallel rectangles. Artif Intell 1997, 89(1-2):31-71.
Yang C, Lozano-Perez T: Image database retrieval with multiple-instance learning
techniques. Proceedings - International Conference on Data Engineering 2000:233-243.
Andrews S, Tsochantaridis I, Hofmann T: Support Vector Machines for MultipleInstance Learning. Adv Neur In 2003, 15:561-568.
Maron O, Ratan AL: Multiple-Instance Learning for Natural Scene Classification.
Proc 15th Int'l Conf on Machine Learning 1998:341-349.
McGregor MJ, Muskal MM: Pharmacophore fingerprint. 1. Application to QSAR
and focused library design. J Chem Inf Comput Sci 1999, 39:569-574.
Mason JS, Morize I, Menard PR, Cheney DL, Hulme C, Labaudiniere RF: New 4-point
pharmacophore method for molecular similarity and diversity applications:
overview of the method and applications, including a novel approach to the design
of combinatorial libraries containing privileged substructures. J Med Chem 1999,
42:3251-3264.
Bradley EK, Beroza P, Penzotti JE, Grootenhuis PDJ, Spellmeyer DC, Miller JL: A
rapid computational method for lead evolution: description and application to
alpha1-adrenergic antagonists. J Med Chem 2000, 43:2770-2774.
Penzotti JE, Lamb ML, Evensen E, Grootenhuis PDJ: A computational ensemble
pharmacophore model for identifying substrates of P-glycoprotein. J Med Chem
2002, 45(9):1737-1740.
Li WX, Li L, Eksterowicz J, Ling XB, Cardozo M: Significance analysis and multiple
pharmacophore models for differentiating P-glycoprotein substrates. J Chem Inf
Model 2007, 47(6):2429-2438.
Willett P, Barnard JM, Downs GM: Chemical similarity searching. J Chem Inf Comp
Sci 1998, 38(6):983-996.
Cohen P, Goedert M: GSK3 inhibitors: Development and therapeutic potential. Nat
Rev Drug Discov 2004, 3(6):479-487.
Pavlopoulos S, Thakur GA, Nikas SP, Makriyannis A: Cannabinoid receptors as
therapeutic targets. Curr Pharm Des 2006, 12(14):1751-1769.
Matheny CJ, Lamb MW, Brouwer KLR, Pollack GM: Pharmacokinetic and
pharmacodynamic implications of P-glycoprotein modulation. Pharmacotherapy
2001, 21(7):778-796.
Tusher VG, Tibshirani R, Chu G: Significance analysis of microarrays applied to the
ionizing radiation response. P Natl Acad Sci USA 2001, 98(9):5116-5121.
Maron O, Lozano-Perez T: A framework for multiple-instance learning. Adv Neur In
1998, 10:570-576.
31

19.
20.
21.
22.
23.

24.

Bi J, Bennett KP, Embrechts M, Breneman C, Song M: Dimensionality reduction via
sparse support vector machines. J Mach Learn Res 2003, 3:1229-1243.
Breiman L, Friedman J, Olshen RA, Stone CJ: Classification and Regression Trees.
Belmont, CA: Wadsworth; 1983.
Breiman L: Random forests. Mach Learn 2001, 45:5-32.
Cortes C, Vapnik V: Support-vector networks. Mach Learn 1995, 20:273-297.
Svetnik V, Liaw A, Tong C, Culberson JC, Sheridan RP, Feuston BP: Random forest: a
classification and regression tool for compound classification and QSAR modeling. J
Chem Inf Comput Sci 2003, 43:1947-1958.
Matthews BW: Comparison of the predicted and observed secondary structure of T4
phage lysozyme. Biochim Biophys Acta 1975, 405(2):442-451.

32

VITA

Education
Ph.D. in Pharmaceutical Science, University of Mississippi
Dissertation: Discovery of Novel Glycogen Synthase Kinase-3β Inhibitors: Molecular Modeling,
Virtual Screening, and Biological Evaluation.
M.S. in Computer & Information Science, University of Mississippi
Thesis: Implementation of Multiple-Instance Learning in Drug Activity Prediction: A
Framework to Identify Bioactive Conformers.
M.S. in Medicinal Chemistry, Peking University Health Science Center, China
Thesis: Rational Design, Synthesis and Biological Evaluation of Novel Peptidomimetics for the
Inhibition of Proteasome.
B.S. in Pharmaceutical Science, Peking University Health Science Center, China

Honors & Awards
University of Mississippi, Oxford, MS


University of Mississippi Graduate Student Achievement Award (one of the two best
graduate students in the School of Pharmacy at University of Mississippi in 2012)



2011 Nobles-Sam Graduate Research Award from the Department of Medicinal Chemistry at
the University of Mississippi, bestowed on the student with the best podium presentation at
the annual MALTO meeting (May 2011)



2011 Graduate Student Research Award presented by American Chemical Society the Ole
Miss Local Section (April 2011)



Research Symposium 2011 Best Poster Award in Pharmaceutical Sciences presented by the
University of Mississippi Graduate Student Council (April 2011)



Graduate Student Council Research Award presented by the Graduate School (Fall 2010)

33



NIH Predoctoral Fellow 2009 sponsored by the Center of Research Excellence in Natural
Products Neuroscience (CORE-NPN) (October 2009)

Peking University Health Science Center, Peking, China


Peking University Yi Yao Scholarship; Awards for excellent student (2005-2006)



Peking University GE Medical Education Scholarship; Awards for excellent student (20042005)



Peking University Second-Class of Excellent Medicinal Student Scholarship (2003-2004)



Dean‟s Award for Physical Excellence (2001-2003)

List of Publications
1. Xiaofei Nan, Gang Fu, Zhendong Zhao, Sheng Liu, Ronak Y. Patel, Haining Liu, Pankaj R.
Daga, Robert J. Doerksen, Xing Dang, Yixin Chen, Dawn Wilkins. “Leveraging Domain
Information to Restructure Biological Prediction.” BMC Bioinformatics, 12, S22 (2011) 15,
(2011 MCBIOS Proceedings).
2. Gang Fu, Robert J. Doerksen, and Ping Xu. “Assignment of absolute configuration of
sulfinyl dilactones: Optical rotations and 1H NMR experiment and DFT calculations.”
Journal of Molecular Structure, (2011) 987, 166-173.
3. Gang Fu, Xiao-Min Zou, Yi-Qiu Fu, De Mou, Chao Ma, Yang Lu and Ping Xu. “Synthesis
of protected aminoalkyl sulfinyl dilactones from α-amino acids.” Journal of Chinese
Pharmaceutical Sciences, (2007) 16, 119-124.
4. Man Xu, Gang Fu, Xue Qiao, Wan-Ying Wu, Hui Guo, Ai-Hua Liu, Jiang-Hao Sun, De-An
Guo. “HPLC method for comparative study on tissue distribution in rat after oral
administration of salvianolic acid B and phenolic acids from Salvia miltiorrhiza.” Biomedical
Chromatography, (2007), 21, 1052-1063.
5. Man Xu, Zichuan Zhang, Gang Fu, Shifeng Sun, Jianghao Sun, Min Yang, Aihua Liu, Jian
Han, Dean Guo. “Liquid chromatography–tandem mass spectrometry analysis of

34

protocatechuic aldehyde and its phase I and II metabolites in rat.” Journal of
Chromatography B, (2007), 856, 100-107.
6. Yiqiu Fu, Bo Xu, Xiaomin Zou, Chao Ma, Xiaoming Yang, Ke Mou, Gang Fu, Yang Lü,
Ping Xu. “Design and synthesis of a novel class of furan-based molecules as potential 20S
proteasome inhibitors.” Bioorganic & Medicinal Chemistry Letters, (2007), 17, 1102-1106.

List of Submitted Manuscripts
7. Gang Fu, Xiaofei, Nan, Haining Liu, Ronak Patel, Pankaj Daga, Yixin Chen, Dawn E.
Wilkins, Robert J. Doerksen. “Implementation of multiple-instance learning in drug activity
prediction to identify bioactive conformers” submitted to BMC Bioinformatics (2012
MCBIOS Proceedings).
8. Sheng, Liu, Ronak Y. Patel, Pankaj R. Daga, Haining Liu, Gang Fu, Robert J. Doerksen,
Yixin Chen, and Dawn E. Wilkins. “Combined rule extraction and feature elimination in
supervised classification” submitted to IEEE Transactions on NanoBioscience (2012).
9. Gang Fu, Prasanna Sivaprakasam, Olivia R. Dale, Susan P. Manly, Stephen J. Cutler, Robert
J. Doerksen. “Pharmacophore modeling, ensemble docking and virtual screening studies on
glycogen synthase kinase-3β.” submitted to Journal of Chemical Information and Modeling
(2012).
10. Gang Fu, Haining Liu, and Robert J. Doerksen. “Induced fit docking, molecular dynamics
simulations, binding energy calculations and QM/MM studies of the catalytic mechanism of
human biliverdin IXα reductase.” submitted to Journal of Physical Chemistry (2012).

List of Manuscripts in Preparation
11. Gang Fu, Robert J. Doerksen. “Recent advances in computational modeling and drug
discovery aspects of glycogen synthase kinase-3” (Review article, in preparation).
12. Gang Fu, Olivia R. Dale, Sheng Liu, Yixin Chen, Dawn E. Wilkins, Susan P. Manly, Stephen

J. Cutler, Robert J. Doerksen. “Hierarchical quantitative structure-activity relationship and
35

virtual screening studies on glycogen synthase kinase-3β.” To be submitted to Journal of
Chemical Information and Modeling (2012).

36

